IMUNON Enters into CRADA for Preclinical Studies of PlaCCine Modality in Preventive Vaccines Against Lassa Virus
August 24, 2023 16:05 ET
|
Imunon, Inc.
CRADA will evaluate the immunogenicity and efficacy of two DNA-based Lassa virus vaccine candidates in animal models LAWRENCEVILLE, N.J., Aug. 24, 2023 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ:...
Curative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study
January 05, 2023 07:50 ET
|
Curative Biotechnology, Inc.
Boca Raton, FL, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments...
NRL, SAFCell Sign CRADA for Exploration of new Class of solid Acid Proton Conductors
May 10, 2022 09:54 ET
|
U.S. Naval Research Laboratory
WASHINGTON, May 10, 2022 (GLOBE NEWSWIRE) -- SAFCell Inc. has signed a Cooperative Research and Development Agreement (CRADA) with the Department of the Navy's U.S. Naval Research Laboratory (NRL). ...
Curative Biotechnology Announces Cooperative Research and Development Agreement (CRADA) with the National Eye Institute (NEI) for Clinical Evaluation of its Proprietary Ocular Metformin Formulation in Age-Related Macular Degeneration
March 21, 2022 09:50 ET
|
Curative Biotechnology, Inc.
Emily Y. Chew, M.D. of the National Eye Institute Assigned Principal Investigator Boca Raton, FL, March 21, 2022 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: CUBT) (“Curative” or the...
FAA and AURA to Support Critical Communications in National Airspace
February 01, 2022 06:00 ET
|
AURA Network Systems
McLean, VA, Feb. 01, 2022 (GLOBE NEWSWIRE) -- AURA Network Systems (AURA) and the Federal Aviation Administration (FAA) have entered into a four-year Cooperative Research and Development Agreement...
LIXTE BIOTECHNOLOGY HOLDINGS, INC. ANNOUNCES THAT ENROLLMENT HAS RESUMED IN NATIONAL CANCER INSTITUTE’S TRIAL TO DETERMINE ABILITY OF LIXTE COMPOUND LB-100 TO ENTER RECURRENT, MALIGNANT BRAIN TUMORS
November 22, 2021 09:25 ET
|
Lixte Biotechnology Holdings, Inc.
PASADENA, CA, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT) announced that the National Cancer Institute (NCI) has resumed enrolling patients into their...
Lightbridge Signs Cooperative R&D Agreement with the U.S. Department of Energy’s Gateway for Accelerated Innovation in Nuclear (GAIN) Program
July 19, 2021 08:00 ET
|
Lightbridge Corporation
RESTON, Va., July 19, 2021 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge,” or the “Company”) (NASDAQ: LTBR), an advanced nuclear fuel technology company, is pleased to announce that it...
Quantum Computing Inc. Enters 3-Year Agreement with Los Alamos National Laboratory in Exascale & Petascale Simulations
June 14, 2021 08:31 ET
|
Quantum Computing Inc.
LEESBURG, Va., June 14, 2021 (GLOBE NEWSWIRE) -- Quantum Computing Inc. (QCI) (OTCQB: QUBT), the leader in bridging the power of classical and quantum computing, today announced a three-year...
SolarWindow Sets New Record, Doubling Its Power Conversion Efficiency
March 30, 2021 08:30 ET
|
SolarWindow Technologies, Inc.
NEW YORK and SEOUL, South Korea, March 30, 2021 (GLOBE NEWSWIRE) -- SolarWindow Technologies, Inc. (Symbol: WNDW), developer of transparent liquid coatings and processes for generating electricity...
DAXOR ANNOUNCES COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT WITH THE UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES
August 04, 2020 08:00 ET
|
Daxor Corporation
NEW YORK, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...